We evaluated the recurrence-free (Figure 2E) and overall (Figure 2F) survival of Cohort 2 HCC patients and found that FOXM1-high HCC patients showed worse recurrence-free (p = 0.059) and overall (p = 0.043) survival compared with FOXM1-low HCC patients. The gene discussed is FOXM1; the disease is hepatocellular carcinoma.